Pharma-Bio Serv Statistics
Total Valuation
Pharma-Bio Serv has a market cap or net worth of 11.45 million. The enterprise value is 890,426.
| Market Cap | 11.45M |
| Enterprise Value | 890,426 |
Important Dates
The next estimated earnings date is Friday, June 12, 2026.
| Earnings Date | Jun 12, 2026 |
| Ex-Dividend Date | Feb 27, 2026 |
Share Statistics
Pharma-Bio Serv has 22.90 million shares outstanding. The number of shares has decreased by -0.13% in one year.
| Current Share Class | 22.90M |
| Shares Outstanding | 22.90M |
| Shares Change (YoY) | -0.13% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 54.99% |
| Owned by Institutions (%) | 1.49% |
| Float | 8.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.30 |
| PB Ratio | 1.12 |
| P/TBV Ratio | 1.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.69 |
| EV / Sales | 0.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.82 |
Financial Position
The company has a current ratio of 4.03
| Current Ratio | 4.03 |
| Quick Ratio | 3.99 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -0.68% and return on invested capital (ROIC) is -166.88%.
| Return on Equity (ROE) | -0.68% |
| Return on Assets (ROA) | -2.70% |
| Return on Invested Capital (ROIC) | -166.88% |
| Return on Capital Employed (ROCE) | -6.25% |
| Weighted Average Cost of Capital (WACC) | 8.55% |
| Revenue Per Employee | 160,450 |
| Profits Per Employee | -1,384 |
| Employee Count | 55 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pharma-Bio Serv has paid 8,718 in taxes.
| Income Tax | 8,718 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.05% in the last 52 weeks. The beta is 0.78, so Pharma-Bio Serv's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +19.05% |
| 50-Day Moving Average | 0.55 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 42.33 |
| Average Volume (20 Days) | 4,281 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, Pharma-Bio Serv had revenue of 8.82 million and -76,139 in losses. Loss per share was -0.00.
| Revenue | 8.82M |
| Gross Profit | 2.86M |
| Operating Income | -640,006 |
| Pretax Income | -67,421 |
| Net Income | -76,139 |
| EBITDA | -574,783 |
| EBIT | -640,006 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 10.56 million in cash and n/a in debt, with a net cash position of 10.56 million or 0.46 per share.
| Cash & Cash Equivalents | 10.56M |
| Total Debt | n/a |
| Net Cash | 10.56M |
| Net Cash Per Share | 0.46 |
| Equity (Book Value) | 10.24M |
| Book Value Per Share | 0.45 |
| Working Capital | 10.01M |
Cash Flow
In the last 12 months, operating cash flow was -175,539 and capital expenditures -9,055, giving a free cash flow of -184,594.
| Operating Cash Flow | -175,539 |
| Capital Expenditures | -9,055 |
| Depreciation & Amortization | 65,223 |
| Net Borrowing | n/a |
| Free Cash Flow | -184,594 |
| FCF Per Share | -0.01 |
Margins
Gross margin is 32.46%, with operating and profit margins of -7.25% and -0.86%.
| Gross Margin | 32.46% |
| Operating Margin | -7.25% |
| Pretax Margin | -0.76% |
| Profit Margin | -0.86% |
| EBITDA Margin | -6.51% |
| EBIT Margin | -7.25% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 15.00%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 15.00% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.13% |
| Shareholder Yield | 15.44% |
| Earnings Yield | -0.66% |
| FCF Yield | -1.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pharma-Bio Serv has an Altman Z-Score of 4.59 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.59 |
| Piotroski F-Score | 2 |